Cannara Biotech Inc. (LOVE) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cannara Biotech, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.065 -- 00:00:04.670 everyone and welcome to canara biotech's fiscal year q2 earnings presentation for the 00:00:04.670 -- 00:00:08.412 three and six months ended february 28 2025. 00:00:08.714 -- 00:00:12.698 my name is scott carroll and i will act as a moderator for today's presentation as a 00:00:12.698 -- 00:00:17.943 reminder this presentation is being recorded following prepared remarks we will conduct 00:00:17.943 -- 00:00:22.008 a question and answer session if you haven't already done so you may submit your questions 00:00:22.008 -- 00:00:27.416 to investors canara.ca or in the chat option in your conference browser. 00:00:27.416 -- 00:00:31.160 Should all submitted questions be addressed today, we will follow up accordingly via 00:00:31.160 -- 00:00:33.042 email. 00:00:33.042 -- 00:00:36.425 Before we begin, please refer to slides two and three of our presentation. 00:00:36.425 -- 00:00:41.370 All information presented today is subject to our general disclaimers on financial measures 00:00:41.370 -- 00:00:47.274 and forward-looking statements, which are also available to be read in detail at cdarplus.ca. 00:00:48.878 -- 00:00:53.861 I will now turn over the call to Nicholas Sosiak, Chief Financial Officer. 00:00:54.098 -- 00:00:58.644 Good morning, everyone. Thank you again for joining our Q2 Earnings webcast. 00:00:58.644 -- 00:01:03.791 My name is Nicholas Soziak, and as CFO of Canara, I have been deeply involved in every 00:01:03.791 -- 00:01:09.299 aspect of this company since 2019. From cultivation to processing, finance, 00:01:09.299 -- 00:01:14.185 strategy, sales and marketing, and product development, we're working alongside our team 00:01:14.185 -- 00:01:16.154 to drive success. 00:01:16.154 -- 00:01:20.922 I'm deeply proud of Canar...